FDA Issues Warning Letter to Regeneca
Adam Gilmer, President and Co-Founder of Regeneca International ( Ethos Environmental Inc ) received a new warning letter from the FDA concerning the company's marketing and distribution of "Regenerect". On the heels of the FDA testing that revealed an analogue of the prescription ingredient in Viagra ( sildenafil ), and a recall on their product, the new warning advises Regeneca that their marketing and distribution of Regenerect violates the Federal Food, Drug and Cosmetic Act.
The FDA warning letter details the fact that Regenerect is labeled as a dietary supplement, but that the labeling statement makes it clear that Regenerect is a drug because it is used to prevent, treat, or curse a condition of the body.
Citing several significant violations, the letter warns Regeneca and Adam Gilmer to take "prompt actions to correct the violations cited in this letter. Failure to promptly correct these violations may result in legal action without further notice."
More Regeneca News and Articles
- Regeneca Shutting Down
- Regeneca Given Distribution Rights for CardioMap
- Regeneca Worldwide Announces New President
- Regeneca Worldwide Recalls RegenESlim Capsules
- FDA Sends Warning Letter to Regeneca
- Regeneca Issues a Voluntary Recall of RegenErect
- Regeneca Issues a Voluntary Recall of RegenArouse
- Regeneca Releases Letter to Shareholders and Distributors
- Regeneca Announces Mobile Technology for Distributors
- Regeneca Announces Successful Launch
- Regeneca Starts Shipping New Improved Formulation for RegenErect
- Regeneca Announces Response to FDA Warning Letter
- FDA Issues Warning Letter to Regeneca
- Regeneca Press Release
- Regenerect Recall Press Release
- Regeneca-Ethos Environmental Press Release
Regeneca Profile
Create a Free Regeneca Rep Listing